ELAN logo

ELAN R&D Expenses

Latest reported$371.00M
ELAN TTM R&D Expenses ($251.80M → $371.00M)
High-resolution chart · PNG

ELAN r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Elanco Animal Health Incorporated Common Stock R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
371,000,000
371,000,000
368,000,000
356,000,000
354,000,000
351,000,000
344,000,000
342,000,000
341,000,000
333,000,000
327,000,000
328,000,000
320,000,000
321,000,000
321,000,000
333,000,000
349,000,000
361,000,000
369,000,000
389,700,000
383,800,000
349,200,000
327,000,000
281,600,000
263,400,000
272,800,000
270,100,000
263,900,000
252,900,000
245,500,000
246,600,000
247,500,000
250,500,000
253,050,000
251,800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.